Custom Antibody Market to reach US$ 700 million by 2027
The global Custom Antibody market gathered revenue around USD 345 million in 2020 and market is set to grow USD 700 million by the end of 2027 and is estimated to expand at a modest CAGR of 12% during the prediction period 2021 to 2027. As such, an increase in research activity-especially in the life sciences industry-along with growing industry-academia collaborations are the primary growth drivers for this market. In addition, the objective behind custom antibody production is to acquire an antibody that performs well in a particular qualitative or quantitative immunodetection method. The quality of catalog antibodies (to ensure the reproducibility of results) is also an area of concern in this market, which is primarily why end users prefer custom-made antibodies.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Custom Antibody market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Custom Antibody market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Custom Antibody market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America accounted for the largest share of the custom antibody market in 2020.
The custom antibody market is broadly segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share in the custom antibody market. The large share of this region can be attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the increasing focus on developing antibody-based therapeutics. The presence of a large number of global players in this region is another key factor contributing to the large share of this market segment.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Custom Antibody Market are:
The major market players include as Thermo Fisher Scientific, Inc. (US), Bio-Rad Laboratories, Inc. (US), Merck Group (Germany), Cell Signaling Technology, Inc. (US), GenScript (China), BioLegend (US), Rockland Immunochemicals (US)
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
The study categorizes the custom antibody market into the following segments and subsegments:
by Service
by Type
by Source
by Research Area
by End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Custom Antibody Market, By Service
7.1. Custom Antibody Market, by Service, 2021-2027
7.1.1. Antibody Development
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Antibody Production & Purification
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Antibody Fragmentation & Labeling
7.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Custom Antibody Market, By Type
8.1. Custom Antibody Market, by Type, 2021-2027
8.1.1. Monoclonal Antibodies
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Polyclonal Antibodies
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Recombinant Antibodies
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Other Custom Antibodies
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Custom Antibody Market, By Source
9.1. Custom Antibody Market, by Source, 2021-2027
9.1.1. Mice
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Rabbits
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Other Sources
9.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Custom Antibody Market, By Research Area
10.1. Custom Antibody Market, by Research Area, 2021-2027
10.1.1. Oncology
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Infectious Diseases
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Neurobiology
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Stem Cells
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Immunology
10.1.5.1. Market Revenue and Forecast (2016-2027)
10.1.6. Cardiovascular Disease
10.1.6.1. Market Revenue and Forecast (2016-2027)
10.1.7. Other Research Areas
10.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 11.Global Custom Antibody Market, By End User
11.1. Custom Antibody Market, by End User, 2021-2027
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Forecast (2016-2027)
11.1.2. Academic & Research Institutes
11.1.2.1. Market Revenue and Forecast (2016-2027)
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Forecast (2016-2027)
Chapter 12.Global Custom Antibody Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Service (2016-2027)
12.1.2. Market Revenue and Forecast, by Type (2016-2027)
12.1.3. Market Revenue and Forecast, by Source (2016-2027)
12.1.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.1.5. Market Revenue and Forecast, by End User (2016-2027)
12.1.6. U.S.
12.1.6.1. Market Revenue and Forecast, by Service (2016-2027)
12.1.6.2. Market Revenue and Forecast, by Type (2016-2027)
12.1.6.3. Market Revenue and Forecast, by Source (2016-2027)
12.1.6.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.1.6.5. Market Revenue and Forecast, by End User (2016-2027)
12.1.7. Rest of North America
12.1.7.1. Market Revenue and Forecast, by Service (2016-2027)
12.1.7.2. Market Revenue and Forecast, by Type (2016-2027)
12.1.7.3. Market Revenue and Forecast, by Source (2016-2027)
12.1.7.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.1.7.5. Market Revenue and Forecast, by End User (2016-2027)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Service (2016-2027)
12.2.2. Market Revenue and Forecast, by Type (2016-2027)
12.2.3. Market Revenue and Forecast, by Source (2016-2027)
12.2.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.2.5. Market Revenue and Forecast, by End User (2016-2027)
12.2.6. UK
12.2.6.1. Market Revenue and Forecast, by Service (2016-2027)
12.2.6.2. Market Revenue and Forecast, by Type (2016-2027)
12.2.6.3. Market Revenue and Forecast, by Source (2016-2027)
12.2.6.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.2.6.5. Market Revenue and Forecast, by End User (2016-2027)
12.2.7. Germany
12.2.7.1. Market Revenue and Forecast, by Service (2016-2027)
12.2.7.2. Market Revenue and Forecast, by Type (2016-2027)
12.2.7.3. Market Revenue and Forecast, by Source (2016-2027)
12.2.7.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.2.7.5. Market Revenue and Forecast, by End User (2016-2027)
12.2.8. France
12.2.8.1. Market Revenue and Forecast, by Service (2016-2027)
12.2.8.2. Market Revenue and Forecast, by Type (2016-2027)
12.2.8.3. Market Revenue and Forecast, by Source (2016-2027)
12.2.8.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.2.8.5. Market Revenue and Forecast, by End User (2016-2027)
12.2.9. Rest of Europe
12.2.9.1. Market Revenue and Forecast, by Service (2016-2027)
12.2.9.2. Market Revenue and Forecast, by Type (2016-2027)
12.2.9.3. Market Revenue and Forecast, by Source (2016-2027)
12.2.9.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.2.9.5. Market Revenue and Forecast, by End User (2016-2027)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Service (2016-2027)
12.3.2. Market Revenue and Forecast, by Type (2016-2027)
12.3.3. Market Revenue and Forecast, by Source (2016-2027)
12.3.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.3.5. Market Revenue and Forecast, by End User (2016-2027)
12.3.6. India
12.3.6.1. Market Revenue and Forecast, by Service (2016-2027)
12.3.6.2. Market Revenue and Forecast, by Type (2016-2027)
12.3.6.3. Market Revenue and Forecast, by Source (2016-2027)
12.3.6.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.3.6.5. Market Revenue and Forecast, by End User (2016-2027)
12.3.7. China
12.3.7.1. Market Revenue and Forecast, by Service (2016-2027)
12.3.7.2. Market Revenue and Forecast, by Type (2016-2027)
12.3.7.3. Market Revenue and Forecast, by Source (2016-2027)
12.3.7.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.3.7.5. Market Revenue and Forecast, by End User (2016-2027)
12.3.8. Japan
12.3.8.1. Market Revenue and Forecast, by Service (2016-2027)
12.3.8.2. Market Revenue and Forecast, by Type (2016-2027)
12.3.8.3. Market Revenue and Forecast, by Source (2016-2027)
12.3.8.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.3.8.5. Market Revenue and Forecast, by End User (2016-2027)
12.3.9. Rest of APAC
12.3.9.1. Market Revenue and Forecast, by Service (2016-2027)
12.3.9.2. Market Revenue and Forecast, by Type (2016-2027)
12.3.9.3. Market Revenue and Forecast, by Source (2016-2027)
12.3.9.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.3.9.5. Market Revenue and Forecast, by End User (2016-2027)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Service (2016-2027)
12.4.2. Market Revenue and Forecast, by Type (2016-2027)
12.4.3. Market Revenue and Forecast, by Source (2016-2027)
12.4.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.4.5. Market Revenue and Forecast, by End User (2016-2027)
12.4.6. GCC
12.4.6.1. Market Revenue and Forecast, by Service (2016-2027)
12.4.6.2. Market Revenue and Forecast, by Type (2016-2027)
12.4.6.3. Market Revenue and Forecast, by Source (2016-2027)
12.4.6.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.4.6.5. Market Revenue and Forecast, by End User (2016-2027)
12.4.7. North Africa
12.4.7.1. Market Revenue and Forecast, by Service (2016-2027)
12.4.7.2. Market Revenue and Forecast, by Type (2016-2027)
12.4.7.3. Market Revenue and Forecast, by Source (2016-2027)
12.4.7.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.4.7.5. Market Revenue and Forecast, by End User (2016-2027)
12.4.8. South Africa
12.4.8.1. Market Revenue and Forecast, by Service (2016-2027)
12.4.8.2. Market Revenue and Forecast, by Type (2016-2027)
12.4.8.3. Market Revenue and Forecast, by Source (2016-2027)
12.4.8.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.4.8.5. Market Revenue and Forecast, by End User (2016-2027)
12.4.9. Rest of MEA
12.4.9.1. Market Revenue and Forecast, by Service (2016-2027)
12.4.9.2. Market Revenue and Forecast, by Type (2016-2027)
12.4.9.3. Market Revenue and Forecast, by Source (2016-2027)
12.4.9.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.4.9.5. Market Revenue and Forecast, by End User (2016-2027)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Service (2016-2027)
12.5.2. Market Revenue and Forecast, by Type (2016-2027)
12.5.3. Market Revenue and Forecast, by Source (2016-2027)
12.5.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.5.5. Market Revenue and Forecast, by End User (2016-2027)
12.5.6. Brazil
12.5.6.1. Market Revenue and Forecast, by Service (2016-2027)
12.5.6.2. Market Revenue and Forecast, by Type (2016-2027)
12.5.6.3. Market Revenue and Forecast, by Source (2016-2027)
12.5.6.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.5.6.5. Market Revenue and Forecast, by End User (2016-2027)
12.5.7. Rest of LATAM
12.5.7.1. Market Revenue and Forecast, by Service (2016-2027)
12.5.7.2. Market Revenue and Forecast, by Type (2016-2027)
12.5.7.3. Market Revenue and Forecast, by Source (2016-2027)
12.5.7.4. Market Revenue and Forecast, by Research Area (2016-2027)
12.5.7.5. Market Revenue and Forecast, by End User (2016-2027)
Chapter 13. Company Profiles
13.1. Thermo Fisher Scientific, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Bio-Rad Laboratories, Inc.
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Merck Group
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Cell Signaling Technology, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GenScript
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. BioLegend
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Rockland Immunochemicals
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers